Population studies showed a decrease in psychological wellbeing during the COVID-19 pandemic. Asthma is associated with a negative effect on anxiety and depression, which might worsen during the COVID-19 lockdown. The aim of the study was to compare fear, anxiety and depression between asthma patients and patients wit hout asthma pre-COVID-19 and during COVID-19 pandemic.

This study compares fear, anxiety and depression in asthma patients and controls between pre-COVID-19 and during COVID-19 lockdown with a cross-sectional online survey. Participants were invited to fill out several questionnaires pertaining to fear, anxiety, depression, asthma control and quality of life.

Asthma patients (N = 37) displayed, during the course of the pandemic, a clinically relevant increase in anxiety (3.32 ± 2.95 vs. 6.68 ± 3.78; p < 0.001) and depression (1.30 ± 1.15 vs. 3.65 ± 3.31; p < 0.001), according to the hospital anxiety and depression levels (HADS) compared to pre-COVID-19 assessment. This was not seen in controls. Also, asthma patients displayed more anxiety about acquiring COVID-19 disease compared to controls ((5.11 ± 1.99 vs. 3.50 ± 2.79), p = 0.006).

Patients with asthma experienced an increase in anxiety and depression levels and were more afraid of acquiring COVID-19 disease compared to controls. Also, patients with asthma were more likely to avoid healthcare facilities due to fear of acquiring COVID-19 disease compared to controls. Therefore, we advise health care workers to address these possible negative effects on mental health by phone or e-consults.

人口研究表明，在 COVID-19 大流行期间，心理健康状况有所下降。哮喘对焦虑和抑郁有负面影响，在 COVID-19 封锁期间可能会恶化。该研究的目的是在 COVID-19 之前和 COVID-19 大流行期间比较哮喘患者和患有哮喘的患者之间的恐惧、焦虑和抑郁。

本研究通过横断面在线调查比较了 COVID-19 之前和 COVID-19 封锁期间哮喘患者和对照组的恐惧、焦虑和抑郁。参与者被邀请填写几份关于恐惧、焦虑、抑郁、哮喘控制和生活质量的问卷。

在大流行过程中，哮喘患者（N = 37）表现出临床相关的焦虑（3.32 ± 2.95 vs. 6.68 ± 3.78；p < 0.001）和抑郁（1.30 ± 1.15 vs. 3.65 ± 3.31；p < 0.001)，根据医院焦虑和抑郁水平 (HADS) 与 COVID-19 之前的评估相比。这在对照中没有看到。此外，与对照组相比，哮喘患者对获得 COVID-19 疾病表现出更多的焦虑（（5.11 ± 1.99 vs. 3.50 ± 2.79），p = 0.006）。

与对照组相比，哮喘患者的焦虑和抑郁水平增加，并且更害怕感染 COVID-19 疾病。此外，与对照组相比，由于害怕感染 COVID-19 疾病，哮喘患者更有可能避开医疗机构。因此，我们建议医护人员通过电话或电子咨询解决这些可能对心理健康造成的负面影响。